Drug Pipeline

IC14 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04488081 I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients COVID-19 Active, Not Recruiting
Phase 1/2
NCT06556810 IC14 for Treatment of Acute Decompensated Heart Failure Acute Decompensated Heart Failure Active, Not Recruiting
NCT06678074 Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI STEMI Active, Not Recruiting
Phase 1
NCT07481474 Pilot and Feasibility Study of Intra-articular Anti-CD14 for the Treatment of Knee… Knee Osteoarthritis (Knee OA) Not Yet Recruiting
Sponsors Running IC14 Trials
Disease Areas
Get alerts when IC14 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free